NVAX and SNY Related Headlines
Go Back- Novavax beats revenue estimates, raises full-year guidance
- Novavax completes US marketing transfer to Sanofi, receives $25 million
- Novavax expands Sanofi license for Matrix-M adjuvant use
- BofA downgrades Novavax stock on vaccine uncertainty
